Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon stock logo
ALC
Alcon
$87.67
-1.8%
$89.25
$80.48
$101.10
$43.30B0.951.20 million shs1.67 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$82.73
-1.0%
$83.26
$57.52
$117.19
$32.52B1.444.41 million shs1.84 million shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$372.84
-1.4%
$371.55
$289.98
$417.14
$90.60B1.471.46 million shs943,125 shs
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$171.50
-0.4%
$162.58
$109.82
$178.76
$15.93B1.641.81 million shs977,101 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon stock logo
ALC
Alcon
0.00%-0.30%+1.98%+4.77%-0.52%
DexCom, Inc. stock logo
DXCM
DexCom
0.00%-4.17%-3.36%+38.28%-25.41%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
0.00%-1.63%-2.46%+12.12%+14.26%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
0.00%-1.23%+0.94%+42.64%+26.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon stock logo
ALC
Alcon
1.8155 of 5 stars
2.43.00.80.01.10.81.3
DexCom, Inc. stock logo
DXCM
DexCom
4.9196 of 5 stars
3.55.00.04.73.42.51.9
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
4.8254 of 5 stars
2.43.02.54.53.32.52.5
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
4.6266 of 5 stars
2.43.00.04.33.42.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon stock logo
ALC
Alcon
2.80
Moderate Buy$106.1321.05% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.95
Moderate Buy$98.5019.06% Upside
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2.74
Moderate Buy$395.716.14% Upside
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
2.89
Moderate Buy$183.947.25% Upside

Current Analyst Ratings Breakdown

Latest ALC, DXCM, HCA, and THC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$376.00 ➝ $404.00
6/16/2025
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$102.00
6/9/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$355.00 ➝ $410.00
6/9/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$175.00 ➝ $210.00
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$366.00 ➝ $416.00
6/2/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/2/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$171.00 ➝ $215.00
5/30/2025
DexCom, Inc. stock logo
DXCM
DexCom
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$104.00
5/29/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$320.00 ➝ $385.00
5/29/2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$150.00 ➝ $195.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon stock logo
ALC
Alcon
$9.91B4.36$5.55 per share15.80$43.70 per share2.01
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B8.04$2.24 per share36.90$5.38 per share15.38
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$70.60B1.27$35.54 per share10.49$2.19 per share170.25
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$20.67B0.77$21.09 per share8.13$61.20 per share2.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon stock logo
ALC
Alcon
$1.02B$2.2538.9626.652.2411.28%6.95%4.92%8/19/2025 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.3461.7433.631.7712.90%30.05%10.00%7/30/2025 (Estimated)
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.76B$22.4916.5813.301.308.07%1,063.91%10.10%7/22/2025 (Estimated)
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$3.20B$15.1211.3412.761.257.09%22.58%4.29%7/22/2025 (Confirmed)

Latest ALC, DXCM, HCA, and THC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45N/AN/AN/A$1.13 billionN/A
7/22/2025Q2 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$6.20N/AN/AN/A$18.49 billionN/A
7/22/2025Q2 2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$2.84N/AN/AN/A$5.16 billionN/A
5/13/2025Q1 2025
Alcon stock logo
ALC
Alcon
$0.77$0.73-$0.04$0.70$2.52 billion$2.33 billion
5/1/2025Q1 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billion
4/29/2025Q1 2025
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
$3.11$4.36+$1.25$4.27$5.15 billion$5.22 billion
4/25/2025Q1 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.75$6.45+$0.70$6.45$18.26 billion$18.32 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon stock logo
ALC
Alcon
N/AN/AN/AN/A4 Years
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$2.880.77%N/A12.81%6 Years
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
N/AN/AN/AN/AN/A

Latest ALC, DXCM, HCA, and THC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
quarterly$0.720.84%6/16/20256/16/20256/30/2025
4/7/2025
Alcon stock logo
ALC
Alcon
annual$0.32700.3%5/14/20255/14/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon stock logo
ALC
Alcon
0.21
2.70
1.66
DexCom, Inc. stock logo
DXCM
DexCom
0.55
1.50
1.32
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
69.07
1.19
1.06
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
2.23
1.78
1.70

Institutional Ownership

CompanyInstitutional Ownership
Alcon stock logo
ALC
Alcon
53.86%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
62.73%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
95.44%

Insider Ownership

CompanyInsider Ownership
Alcon stock logo
ALC
Alcon
1.52%
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1.30%
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
0.81%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon stock logo
ALC
Alcon
25,599493.24 million485.75 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.11 million390.85 millionOptionable
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
316,000240.57 million237.45 millionOptionable
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
98,00092.89 million92.13 millionOptionable

Recent News About These Companies

2 hospitals tap former Tenet facility CEO as CFO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcon stock logo

Alcon NYSE:ALC

$87.67 -1.63 (-1.82%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$87.67 0.00 (0.00%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

DexCom stock logo

DexCom NASDAQ:DXCM

$82.73 -0.85 (-1.02%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$82.87 +0.14 (+0.17%)
As of 07/3/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

HCA Healthcare stock logo

HCA Healthcare NYSE:HCA

$372.84 -5.20 (-1.38%)
Closing price 07/3/2025 03:37 PM Eastern
Extended Trading
$372.84 0.00 (0.00%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Tenet Healthcare stock logo

Tenet Healthcare NYSE:THC

$171.50 -0.72 (-0.42%)
As of 07/3/2025 03:30 PM Eastern

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.